ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non-small-cell Lung Cancer

Zhao, MengYang*; Tang, ZiBo; Wang, YiJun; Ding, JiaoJiao; Guo, Ying; Zhang, Ning; Gao, TianHui南方医科大学; 郑州大学
American Journal of Cancer Research2021DOI: 10.7150/jca.60724
4被引12阅读
引用收藏
分享

摘要

Lung cancer is a serious threat to human health due to its high morbidity and mortality. microRNAs (miRNAs) are involved in the tumorigenesis and progression of lung cancer. In this study, we elucidated the role of miRNA-4507 (miR-4507) in the pathogenesis of non-small-cell lung cancer (NSCLC). miR-4507 is found to be upregulated in NSCLC cells (A549, H460). MTT, 5-ethynyl-2'-deoxyuridine (EdU), wound healing, and transwell assays were performed to evaluate NSCLC cell proliferation and migration. The results demonstrated that miR-4507 inhibition significantly decrease the proliferation and migration of NSCLC cells. Subsequently, a luciferase activity assay was conducted to verify the regulation of the predicted gene target of miR-4507, namely, TPS3. Mechanism experiments show that miR-4507 activates the PI3K/AKT signal. Further, we co-transfected miR-4507 mimics and TPS3 plasmids and found that TPS3 overexpression could recover the effects of miR-4507 mimics on proliferation, migration, and the PI3K/AKT signal activation. These results suggested that miR-4507 targets TPS3 to facilitate the proliferation and migration of lung cancer cells through PI3K/AKT signal and that miR-4507 could serve as a potential target for NSCLC treatment.

学科与关键词

关键词
miR-4507migrationnon-small-cell lung cancerproliferationTP53
相关
加载中…
  • Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta
    Shi, Lin; Kan, Jun; Zhuo, Lin; Wang, Siyun; Chen, Shaobing; Zhang, Bei*; Ke, Bin*FEBS Journal, 2023, 290(4): 1134-1150.被引 2
  • miR-4732-3p prevents lung cancer progression via inhibition of the TBX15/TNFSF11 axis
    Li, Pengfei; Li, Ying; Bai, Shuping; Zhang, Yu; Zhao, Ling*Epigenomics, 2023, 15(4).
  • Clinical Significance and Biological Function of miR-1274a in Non-small Cell Lung Cancer
    Zhu, Shi-jia; Wang, Xiao; Hu, Song-liu; Fang, Yu; Guan, Bi-xi; Li, Jian; Li, Gen; Xu, Jian-yu*MOLECULAR BIOTECHNOLOGY, 2022, 64(1): 9-16.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
American Journal of Cancer Research
发表日期
2021
卷期
第 12 卷, 第 22 期
页码
6600-6609
DOI
10.7150/jca.60724
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Youth Program of National Natural Science Foundation of China (NSFC) [81702672]

作者

  • Z

    Zhao, MengYang (通讯) (第一作者)

    henan prov peoples hosp · zhengzhou univ

  • T

    Tang, ZiBo

    2 · southern med univ

查看全部 7 位作者收起作者
  • W

    Wang, YiJun

    henan prov peoples hosp · zhengzhou univ

  • D

    Ding, JiaoJiao

    henan prov peoples hosp · zhengzhou univ

  • G

    Guo, Ying

    henan prov peoples hosp · zhengzhou univ

  • Z

    Zhang, Ning

    henan prov peoples hosp · zhengzhou univ

  • G

    Gao, TianHui

    henan prov peoples hosp · zhengzhou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417